Physician

Aron W Berkman, M.D.

According to 2025 Medicare claims, Aron Berkman, M.D. (NPI: 1447347851) practices medical oncology in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC (NPI: 1679978118; TIN: 471859521) and primary practice location at 33174-2555.

Berkman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 11 traditional Medicare patients, billed 35 HCPCS/CPT codes, and received $2,732 in Medicare payments. Part D data shows 26 prescription claims totaling $334,916 in drug costs, led by Revlimid (Lenalidomide). 2016 DME data shows 11 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $21,917 to $2,732. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $519,842 and ending at $334,916. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$12K$23K2015 Medicare payment: $21,917 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $23,160 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,317 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $10,150 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $7,230 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $7,290 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,458 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,539 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,803 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,732 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201550278$21,917
201683257$23,160
20172290$5,317
201826177$10,150
201918107$7,230
202017123$7,290
20211460$5,458
20221356$5,539
20231262$5,803
20241135$2,732

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$297K$594K2015 Drug cost: $519,842 (USD; Tot_Drug_Cst)2016 Drug cost: $96,204 (USD; Tot_Drug_Cst)2017 Drug cost: $137,210 (USD; Tot_Drug_Cst)2018 Drug cost: $482,541 (USD; Tot_Drug_Cst)2019 Drug cost: $531,481 (USD; Tot_Drug_Cst)2020 Drug cost: $505,363 (USD; Tot_Drug_Cst)2021 Drug cost: $593,863 (USD; Tot_Drug_Cst)2022 Drug cost: $465,283 (USD; Tot_Drug_Cst)2023 Drug cost: $327,855 (USD; Tot_Drug_Cst)2024 Drug cost: $334,916 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201554401$519,842
201650296$96,204
201722123$137,210
201823201$482,541
201914152$531,481
202016180$505,363
20211190$593,863
2022N/R58$465,283
2023N/R34$327,855
2024N/R26$334,916

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$303$6062016 Medicare payment: $606 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R11$606
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide14392$334,700

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Aron W. Berkman, M.D.?

Tedicare shows public-source Medicare data for Aron W. Berkman, M.D. (NPI 1447347851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aron W. Berkman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aron W. Berkman, M.D.?

Aron W. Berkman, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP ONCOLOGY LLC (billing NPI 1679978118) in the available physician profile data.

Does Aron W. Berkman, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.